Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
Teva's CEO Was $2.8 Billion Down on His Second Day on the Job - Bloomberg
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - Bloomberg
America's Most Beloved Pharmaceutical Stock Is Israel's Teva - Bloomberg
Teva flags supply constraints to ADHD drug Adderall as demand rises (NYSE: TEVA) | Seeking Alpha
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Kare Schultz, president and chief executive officer of Teva... Fotografía de noticias - Getty Images
Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion - Bloomberg
Teva Analysts Say Migraine Drug Approval Gives Needed Relief - Bloomberg
Teva Pharmaceuticals CEO steps down as shares continue descent - BNN Bloomberg
Teva's Adderall Shortage Expected to Continue Into March, FDA Says - BNN Bloomberg
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
Teva CEO Resigns; Dividend Cut Should Be Next - Bloomberg
Teva Loses CEO, Leaving Investors to Guess What's Next - Bloomberg
How Uggs, Hoka, and Tevas Helped Build Deckers' $2.5 Billion Ugly-Shoe Empire - Bloomberg
Teva to Sell Assets Such as Women's Health Unit to Cut Debt - Bloomberg
Phillip Frost, billionaire and chairman of Teva Pharmaceutical... Fotografía de noticias - Getty Images
Teva, Allergan ready to pay $5B to settle thousands of opioid lawsuits (TEVA) | Seeking Alpha
Teva's Budding Blockbuster Drugs Lend Respite From Legal Concerns - Bloomberg
Buffett's Berkshire Takes Activision Blizzard Stake, Exits Teva - BNN Bloomberg
Teva Considers 10,000 Job Cuts - Bloomberg
Teva Pharmaceuticals Sued by U.S. Over Medicare Kickback Claims - BNN Bloomberg
Soriot not moving to Teva - Bloomberg - Globes
Teva considering cutting up to 10,000 jobs: Bloomberg
Drugmaker Teva Misled Court to Dodge Opioid Trial, New York State Claims - Bloomberg
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
